1. Home
  2. MMI vs XERS Comparison

MMI vs XERS Comparison

Compare MMI & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMI
  • XERS
  • Stock Information
  • Founded
  • MMI 1971
  • XERS 2005
  • Country
  • MMI United States
  • XERS United States
  • Employees
  • MMI N/A
  • XERS 394
  • Industry
  • MMI Real Estate
  • XERS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MMI Finance
  • XERS Health Care
  • Exchange
  • MMI Nasdaq
  • XERS Nasdaq
  • Market Cap
  • MMI 1.2B
  • XERS 1.3B
  • IPO Year
  • MMI 2013
  • XERS 2018
  • Fundamental
  • Price
  • MMI $32.83
  • XERS $7.99
  • Analyst Decision
  • MMI Sell
  • XERS Strong Buy
  • Analyst Count
  • MMI 2
  • XERS 7
  • Target Price
  • MMI $30.00
  • XERS $8.00
  • AVG Volume (30 Days)
  • MMI 127.3K
  • XERS 3.5M
  • Earning Date
  • MMI 08-07-2025
  • XERS 08-07-2025
  • Dividend Yield
  • MMI 1.54%
  • XERS N/A
  • EPS Growth
  • MMI N/A
  • XERS N/A
  • EPS
  • MMI N/A
  • XERS N/A
  • Revenue
  • MMI $725,903,000.00
  • XERS $246,025,000.00
  • Revenue This Year
  • MMI $12.22
  • XERS $43.89
  • Revenue Next Year
  • MMI $23.33
  • XERS $20.40
  • P/E Ratio
  • MMI N/A
  • XERS N/A
  • Revenue Growth
  • MMI 17.89
  • XERS 35.62
  • 52 Week Low
  • MMI $27.61
  • XERS $2.48
  • 52 Week High
  • MMI $42.80
  • XERS $8.02
  • Technical
  • Relative Strength Index (RSI)
  • MMI 62.07
  • XERS 82.24
  • Support Level
  • MMI $30.62
  • XERS $7.27
  • Resistance Level
  • MMI $32.90
  • XERS $8.02
  • Average True Range (ATR)
  • MMI 0.78
  • XERS 0.34
  • MACD
  • MMI 0.27
  • XERS 0.04
  • Stochastic Oscillator
  • MMI 98.35
  • XERS 97.97

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Share on Social Networks: